This site is intended for health professionals only

Published on 22 June 2007

Share this story:

RELATED ARTICLES
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
GSK3036656 demonstrates antibacterial action in pulmonary tuberculosis after two weeks
Mindfulness-based stress reduction non-inferior to escitalopram for anxiety disorders
Malarial monoclonal antibody highly effective at 6 months
Nirsevimab receives EMA approval for RSV in newborns and infants

US go-ahead for Exforge

teaser

Novartis has received US approval for Exforge



Most read

1
Feedback: Automation systems in your hospital
2
Merck agrees huge Vioxx settlement
3
Janssen-Cilag’s Stelara approved by NICE
4
Helapet introduce new, improved 20mm Vented Vial Adapter
5
Encouraging results for SLE treatment



Latest Issue

Read the latest issue >
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
PN: A new focus of patient-centred care
Ruxolitinib for the treatment of myelofibrosis
Fujifilm gets in pharma picture with Toyama offer
Epilepsy: management and pharmacotherapy
Organisations join forces to create global alliance against antibiotic resistance

Download Hospital Pharmacy Europe free app

Download our app from the Apple App Store Download our app from Google Play

© Cogora 2022
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora